Community Pharmacy England (CPE) has expressed dissatisfaction with the spring budget as it brings "no specific relief" for the community pharmacy sector,
which is grappling with "soaring costs and severe medicine supply and pricing issues."
UK Chancellor Jeremy Hunt announced his Spring Budget on Wednesday, confirming an extra £2.5 billion in day-to-day revenue funding for the NHS in England in 2024-25
and a new NHS productivity plan worth £3.4bn to modernise IT systems.
The Chancellor said that day-to-day spending would grow by 1 per cent per year on average in real terms, and the productivity plan is estimated to "unlock £35
billion worth of savings" from 2025-26 to 2029-30.
However, CPE chief executive, Janet Morrison commented that the budget has "no obvious good news" for community pharmacies who need "urgent relief from the ongoing
unsustainable funding and operational pressures" they are facing.
Morrison described the investment in Pharmacy First as "the most significant investment in pharmacies in a decade", but emphasised the need for further support to
stabilise the sector and its core contractual arrangements.
Recognising her remarkable contribution in the profession of pharmacy, Christine Gilmour, the Director of Pharmacy at NHS Lanarkshire, has been designated
as a Fellow of the Royal Pharmaceutical Society (RPS).
Christine, who joined NHS Lanarkshire as trust chief pharmacist for University Hospital Hairmyres and Stonehouse in 1994. She has been in her current role as
Director of Pharmacy for 17 years now.
Considered to be one of the highest accolades in the domain of pharmacy, this fellowship recognises the distinction of an RPS member in the pharmacy career.
NHS Lanarkshire executive medical director, Dr Chris Deighan commented: "We are extremely proud of Christine. This is a fantastic achievement and recognises
all the hard work, dedication and expertise Christine has displayed across her career."
Derriford Hospital is set to move its outpatient pharmacy to a bigger unit, which will be twice as big as the current size.
The new pharmacy, due to open in Spring 2024, is located adjacent to the hospital's on-site Costa Coffee shop in the multistorey car park building.
University Hospitals Plymouth NHS Trust said work is ongoing on the new 155 square metres pharmacy, but measures such as covered seating has been implemented.
Additionally, the pharmacy's opening times would be extended during the weekends to benefit patients who are unable to attend during the week, the Trust said,
noting that demand for its services has grown by 25 per cent.
Kandarp Thakkar, Chief Pharmacist & Clinical Director of Medicines Optimisation, said the pharmacy serves thousands of outpatient appointments each week.
Professor Mahendra Patel OBE, CEO of the Oxford University Centre for Research Equity (CfRE), has been appointed as an independent expert member of the UK
Pharmacy Professional Leadership Advisory Board.
The newly established Board comprises nine independent expert members (IEMs) with outstanding leadership capabilities, who were appointed through open recruitment,
ensuring a "broad, balanced, and diverse" representation.
Sir Hugh Taylor KCB, the Independent Chair of the Board, and the UK Chief Pharmaceutical Officers (CPhOs) - Andrew Evans (Wales), Cathy Harrison (Northern Ireland),
Alison Strath (Scotland), and David Webb (England) - announced the appointment of IEMs in an open letter to the UK pharmacy professions.
"Bringing a wealth of experience and expertise, they will play a pivotal role in the Board's work to deliver an exciting vision through supporting a new and dynamic
phase of collaboration," the CPhOs said.
As the CEO of CfRE, Professor Patel spearheads efforts aimed at addressing inequalities in healthcare.
In a move towards greater diversity and inclusivity, the National Pharmacy Association (NPA) has welcomed three accomplished women to its board of key members.
Aisling O'Brien, Sukhi Basra, and Sehar Shahid-who is the youngest member- have joined the board, marking a significant step in the organisation's commitment
to equality and representation.
The announcement, made on the occasion of the International Women's Day, by chief executive, Paul Rees MBE via X reflects the organisation's dedication to
celebrating and empowering women in the pharmacy profession.
Sukhi Basra, the inaugural female board member since last April, adds a valuable dimension to the NPA. With her role as a Community Pharmacy KCW committee
member and her experience in clinical pharmacy spanning over 25 years, she brings a wealth of knowledge and a distinctive viewpoint.
Community Pharmacy England (CPE) highlighted the untapped potential of community pharmacies in the prevention and management of long-term conditions to
Conservative MPs during an event last week.
The roundtable discussion was attended by a select group of influential and supportive MPs alongside community pharmacy owners, the Chief Executive of Community
Pharmacy England, the Director of NHS Services, and patient representative group Healthwatch.
MPs in attendance included Steve Double, MP for St Austell and Newquay, who chaired the discussion; Will Quince MP, former Minister for Pharmacy, Derek Thomas
MP, Sir Peter Bottomley and Peter Aldous MP.
They talked about the current pressures and funding crisis in community pharmacy, exploring solutions on how this could be eased and the huge benefits that can
be unlocked.
Britain's drug regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) on Monday announced that fluoroquinolone antibiotics must only be
administered when no other antibiotics are appropriate for use.
It elaborated that fluoroquinolones given systemically (by mouth, injection, or inhalation) should only be prescribed "when other recommended antibiotics have
failed, will not work due to resistance, or are unsafe to use in an individual patient."
Previous regulations on fluoroquinolones stated that this class of antibiotics should not be prescribed for mild to moderate or self-limiting infections, or
non-bacterial conditions.
Further restrictions have been introduced after receiving reports from patients who have experienced long-lasting or disabling reactions following use of
fluoroquinolones, the MHRA revealed.
Dr Alison Cave, MHRA Chief Safety Officer, said: "Patient safety is our top priority. We have listened to the experience of patients regarding long-lasting
and potentially irreversible adverse reactions following use of fluoroquinolone antibiotics, in some cases prescribed for mild-to-moderate infections.
Health and Social Care Secretary, Wes Streeting, visited St Margaret's Hospital in Epping, West Essex, on Thursday (1 August) as part of an ongoing series
of planned engagements with NHS trusts across England.
Accompanied by NHS Chief Executive, Amanda Pritchard, Streeting observed how NHS staff are using innovative technology to monitor patients at home and prevent
unnecessary hospital admissions.
He met with staff from the hospital's Care Coordination Centre and the 'hospital at home' hub, which work to reduce unnecessary A&E admissions and facilitate
quick and safe discharges home.
Before the hospital tour, the health secretary met the trust's falls response team, which uses a specially equipped 'falls car' to assist patients who have
fallen at home, preventing A&E visits.
Later, Streeting visited the Ross Practice GP surgery in Harlow before holding a town hall event with health leaders in the region.
The General Pharmaceutical Council (GPhC) has strongly condemned recent acts of racism, violence, and disorder caused by far-right, anti-immigrant protestors
across the UK.
Roz Gittins, chief pharmacy officer at GPhC, expressed deep concern for the safety of pharmacy teams, particularly those from Black and minority ethnic backgrounds.
He said: "We strongly condemn the racism, violence and disorder caused by a small minority of the population that has taken place over recent days."
"We understand that pharmacy teams serving our communities may feel especially vulnerable at this time."
"Pharmacists and pharmacy technicians from black and minority ethnic backgrounds, as well as those who trained abroad, make an enormous contribution to our
pharmacy and health services and they should never have to feel fear when going to work.